Aphria offers 90% upside, but this return won’t come for freeRead More»
Internationally renowned for his salient predictions of market bubbles, Chris provides global investment insights in his weekly column 'Macro Battleship'.
Dutch Bros is Starbucks for the next generation. Learn what it does different and more importantly what its worth.Read More»
We compare and contrast Traeger and Weber to see which IPO is worth your money.Read More»
As we feared and warned investors about earlier, the company has announced today that it is doing a at-the-market equity raise program valued at $49M.Read More»
Grizzle outlines the structural share price upside of Compass Pathways and its psilocybin drug: COMP 360 to treat depression.Read More»
Grizzle sits down with Terry Chong (Partner, Grizzle Venture) to discuss one of the most anticipated psychedelic IPOs: Compass PathawaysRead More»